🔎 Trials Near Me

Gara Jalqabaatti › Tumaara Wilms › New York

Qorannoo klinikaalii Tumaara Wilms New York keessatti

Qorannoo 6 Tumaara Wilms f New York keessatti hirmaatuu jiru.

Magaalota New York keessatti

Takkalaa qorannoo (Ingiliffa)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • New York Medical College, Valhalla
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 39 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT04616560

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

  • Albany Medical Center, Albany
  • Roswell Park Cancer Institute, Buffalo
  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
  • fi 9 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 30 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04322318

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
12 Months · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT05985161

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies

  • New York Medical College, Valhalla
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04308330

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's Hospital at Montefiore, The Bronx
Namoota walitti qabaa jiraSadarkaa 2
18 Months – 40 Years · Saalaa hunda · Haaromfame 12-Hag-2025 · NCT05135975

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.